Why I’d sell GKN plc to buy this world-class small-cap competitor

GKN plc (LON: GKN) just can’t compete with this small-cap.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in international engineering giant GKN (LSE: GKN) fell in early deals this morning after it published results for the first six months of 2017. 

The company reported that pre-tax profits rose to £559m in the first six months, up from £182m in the same period last year. Headline sales increased 15% to £5.2bn the period, although trading margins declined by two basis points to 8.4%. Excluding one-off factors, and according to management’s own interpretation of the figures, overall organic trading profit increased by £7m for the period with a currency benefit of £47m and an £8m charge due to acquisitions/divestments. Along with these mixed results, it also said it is paying £250m to help address the deficit in its defined benefit pension scheme which was closed in March. At the end of June, the pension deficit stood at £1.1bn.

Mixed figures 

Over the past five years, GKN has grown steadily, increasing sales by around 9% per annum on average. However, this growth has failed to make its way to the bottom line with pre-tax profit falling from £568m in 2012 to £292m in 2016. Over the same period, earnings per share have risen, but only just, growing by a total of 19%, or around 4% per annum. 

Should you invest £1,000 in Ocado right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Ocado made the list?

See the 6 stocks

The divergence between revenue and profit growth means that GKN’s return on capital has declined from around 13.7% in 2013 to 5.3% for 2016 and return on equity has declined from 32.9% to 12.1%. In other words, the company is becoming less productive as it prioritises sales growth over income.

Deserves a low valuation 

Based on current city estimates, the shares are trading at a forward P/E of 9.5, which might seem attractive to bargain hunters but considering the group’s stagnant profits and falling efficiency, this low multiple seems about right.

By comparison, smaller peer Trifast (LSE: TRI) has been able to grow net profit at a compound annual rate of 32.1% for the past five years as revenue has grown by 10.6% per annum. It has been able to grow earnings faster than revenue because the group has become more productive as it has acquired new businesses to help boost organic growth. Return on capital has increased from 8.8% in 2012 to 14.6% for fiscal 2017. 

Based on these figures, it’s no surprise that shares in Trifast have outperformed those of GKN, rising 411% since mid-2012 excluding dividends. GKN has only clocked up a performance of 50%. Over the next two years, city analysts have pencilled in earnings per share growth of 30% for Trifast as the company continues to grow organically and through acquisitions.

Worth paying a premium for

Compared to GKN, Trifast’s shares are expensive, trading at a forward P/E of 16.7. Nonetheless, this multiple does not seem overly expensive when you take account of Trifast’s robust historic expansion and future potential. 

If management can keep the company on its current course, this multiple could actually undervalue the firm’s long-term potential.

Should you invest £1,000 in Ocado right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Ocado made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK owns shares of GKN. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

3 beaten-down shares to consider buying before the next bull market

Instead of waiting for stocks to start moving higher, Stephen Wright thinks investors should look for shares that might be…

Read more »

Black father and two young daughters dancing at home
Investing Articles

UK investors piled into these S&P 500 stocks during the Liberation Day sell-off…

Our writer wasn't surprised to see AJ Bell investors buying into the S&P 500 earlier this month, though one popular…

Read more »

UK coloured flags waving above large crowd on a stadium sport match.
Investing Articles

A stunning 10% dividend-yield stock to consider for a Stocks and Shares ISA!

Harvey Jones says Stocks and Shares ISA investors should consider FTSE 250 fund manager aberdeen, a recovery stock that pays…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

Here’s why the AstraZeneca share price dipped 3.7% in the FTSE 100 today

Despite AstraZeneca’s falling share price today, this writer believes the London-listed pharmaceutical giant could be worth a closer look.

Read more »

Photo of a man going through financial problems
Investing Articles

I asked ChatGPT to name 3 growth stocks to consider buying in today’s dip. Here they are!

Harvey Jones wants to use the stock market sell-off to buy some great value growth stocks and decided to call…

Read more »

Serious thinking young woman
Investing Articles

Are Associated British Food shares now one of the FTSE 100’s greatest bargains?

Associated British Food (ABF) shares have slumped on news of tough retail conditions. Is the FTSE 100 stock now too…

Read more »

Businessman hand stacking up arrow on wooden block cubes
Growth Shares

Putting £450 in the stock market each month could be worth this much in a decade

Jon Smith explains which sectors could offer high growth potential for the coming decade and how to make the stock…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

As H1 results send the Associated British Foods (ABF) share price down 8%, is it time to buy?

This blip in the ABF share price on interim results day might be just the buying opportunity that patient long-term…

Read more »